4//SEC Filing
Andreessen Horowitz Fund IV, L.P. 4
Accession 0001209191-20-041831
CIK 0001481646other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 8:27 PM ET
Size
30.8 KB
Accession
0001209191-20-041831
Insider Transaction Report
Form 4
Accolade, Inc.ACCD
Andreessen Marc L
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+153,346$77→ 1,603,759 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+15,334$8→ 1,619,089 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−153,346→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2026-07-26→ Common Stock (153,346 underlying) - Sale
Common Stock
2020-07-07$22.00/sh−4$88→ 1,603,755 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Sale
Common Stock
2020-07-07$22.00/sh−1$22→ 1,619,088 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Conversion
Series E Preferred Stock
2020-07-07−695,764→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)→ Common Stock (1,450,413 underlying) - Conversion
Common Stock
2020-07-07+1,450,413→ 1,450,413 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−15,334→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2028-03-16→ Common Stock (15,334 underlying)
Andreessen Horowitz Fund IV, L.P.
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+153,346$77→ 1,603,759 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+15,334$8→ 1,619,089 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−15,334→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2028-03-16→ Common Stock (15,334 underlying) - Conversion
Series E Preferred Stock
2020-07-07−695,764→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)→ Common Stock (1,450,413 underlying) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−153,346→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2026-07-26→ Common Stock (153,346 underlying) - Sale
Common Stock
2020-07-07$22.00/sh−1$22→ 1,619,088 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Conversion
Common Stock
2020-07-07+1,450,413→ 1,450,413 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Sale
Common Stock
2020-07-07$22.00/sh−4$88→ 1,603,755 total(indirect: By Andreessen Horowitz Fund IV, L.P.)
Andreessen Horowitz Fund IV-B, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-07-07$22.00/sh−1$22→ 1,619,088 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Conversion
Series E Preferred Stock
2020-07-07−695,764→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)→ Common Stock (1,450,413 underlying) - Conversion
Common Stock
2020-07-07+1,450,413→ 1,450,413 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+153,346$77→ 1,603,759 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Sale
Common Stock
2020-07-07$22.00/sh−4$88→ 1,603,755 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+15,334$8→ 1,619,089 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−153,346→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2026-07-26→ Common Stock (153,346 underlying) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−15,334→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2028-03-16→ Common Stock (15,334 underlying)
Andreessen Horowitz Fund IV-Q, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2020-07-07+1,450,413→ 1,450,413 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+153,346$77→ 1,603,759 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+15,334$8→ 1,619,089 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Sale
Common Stock
2020-07-07$22.00/sh−1$22→ 1,619,088 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Conversion
Series E Preferred Stock
2020-07-07−695,764→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)→ Common Stock (1,450,413 underlying) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−15,334→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2028-03-16→ Common Stock (15,334 underlying) - Sale
Common Stock
2020-07-07$22.00/sh−4$88→ 1,603,755 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−153,346→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2026-07-26→ Common Stock (153,346 underlying)
HOROWITZ BENJAMIN A
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+153,346$77→ 1,603,759 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Sale
Common Stock
2020-07-07$22.00/sh−4$88→ 1,603,755 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Sale
Common Stock
2020-07-07$22.00/sh−1$22→ 1,619,088 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Conversion
Series E Preferred Stock
2020-07-07−695,764→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)→ Common Stock (1,450,413 underlying) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−15,334→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2028-03-16→ Common Stock (15,334 underlying) - Conversion
Common Stock
2020-07-07+1,450,413→ 1,450,413 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+15,334$8→ 1,619,089 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−153,346→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2026-07-26→ Common Stock (153,346 underlying)
Andreessen Horowitz Fund IV-A, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-07-07$22.00/sh−4$88→ 1,603,755 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+15,334$8→ 1,619,089 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Sale
Common Stock
2020-07-07$22.00/sh−1$22→ 1,619,088 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Conversion
Series E Preferred Stock
2020-07-07−695,764→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)→ Common Stock (1,450,413 underlying) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−153,346→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2026-07-26→ Common Stock (153,346 underlying) - Conversion
Common Stock
2020-07-07+1,450,413→ 1,450,413 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Common Stock
2020-07-07$0.00/sh+153,346$77→ 1,603,759 total(indirect: By Andreessen Horowitz Fund IV, L.P.) - Exercise of In-Money
Warrant (Right to Buy)
2020-07-07−15,334→ 0 total(indirect: By Andreessen Horowitz Fund IV, L.P.)Exercise: $0.00Exp: 2028-03-16→ Common Stock (15,334 underlying)
Footnotes (6)
- [F1]The Series E Preferred Stock automatically converted into shares of Common Stock of the Issuer on a 1:2.084634091 basis immediately upon closing of the Issuer's initial public offering and had no expiration date.
- [F2]These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P. (collectively the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV") is the general partner of the AH Fund IV Entities and has sole voting and dispositive power with regard to the securities held by the AH Fund IV Entities. The managing members of AH EP IV are Marc Andreessen and Benjamin Horowitz. Marc Andreessen and Benjamin Horowitz share voting and dispositive power with respect to the securities held by the AH Fund IV Entities.
- [F3](Continued from Footnote 3) Such persons and entities disclaim the existence of a "group" and disclaim beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of his or its pecuniary interest, if any, in such securities by virtue of his or its interest in the AH Fund IV Entities and/or AH EP IV, as applicable.
- [F4]Upon closing of the Issuer's initial public offering, Andreessen Horowitz Fund IV, L.P. exercised a warrant to purchase 153,346 shares of the Issuer's Common Stock at an exercise price per share of $0.0005. Andreessen Horowitz Fund IV, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 4 shares subject to the warrant in order to pay the exercise price and issuing to Andreessen Horowitz Fund IV, L.P. the remaining 153,342 shares of Common Stock.
- [F5]Upon closing of the Issuer's initial public offering, Andreessen Horowitz Fund IV, L.P. exercised a warrant to purchase 15,334 shares of the Issuer's Common Stock at an exercise price per share of $0.0005. Andreessen Horowitz Fund IV, L.P. paid the exercise price on a cashless basis, resulting in the Issuer withholding 1 share subject to the warrant in order to pay the exercise price and issuing to Andreessen Horowitz Fund IV, L.P. the remaining 15,333 shares of Common Stock.
- [F6]The shares subject to this warrant were fully vested prior to exercise.
Documents
Issuer
Accolade, Inc.
CIK 0001481646
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001603198
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 8:27 PM ET
- Size
- 30.8 KB